期刊文献+

不同剂量瑞托伐他汀治疗高血脂症的疗效观察 被引量:3

下载PDF
导出
摘要 目的研究不同剂量瑞托伐他汀治疗高血脂症的疗效。方法 43高血脂患者随机分为观察组和对照组,观察组予以瑞舒伐他汀20mg/d,对照组予以瑞舒伐他汀10mg/d,观察4周后,两组血脂包括低密度脂蛋白(LDL-C)、总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白(HDL-C),肾功能包括肌酐(Cr),尿素氮(BUN)、谷丙转氨酶(ALT)、肌酸磷酸肌酸(CK)的变化。结果治疗4周后,观察组的LDL-C、TG、TC较对照组均显著降低(P<0.05),BUN、Cr、ALT、CK两组差异无显著性。结论更大剂量瑞舒伐他汀能起到更好调脂作用。
出处 《中国医药指南》 2013年第28期84-85,共2页 Guide of China Medicine
  • 相关文献

参考文献7

  • 1BONAA KH,THELLE DS.Association between blood pressure and serum lipids in a population,the Tromso study [J].Circulation, 1991,83(4):1305-1314.
  • 2Heart Protection Study Collaborative Group.MRC/BHF Heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals.a randomized placebo-con-trolled trial [J]. Lancet,2002,360(9326):7-22.
  • 3李建勇,胡大一,仝其广,史旭波,吴明营,陈捷.中国医师血脂异常防治知识调查[J].中华内科杂志,2005,44(6):461-463. 被引量:23
  • 4Degorter MK,Tirona RG,Schwarz UI,et al.Clinical and Pharmac- ogenetic Predictors of Circulating Atorvastatin and Rosuvasta tinConcentration in Routine Clinical Care[J]. Circ Cardiovasc Genet,2013,6(4):400-408.
  • 5Sardella G,Lucisano L,Mancone M,et al.Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis.The ROMA II trial[J], lnt J Cardiol,2013, Jul 11 .doi:pii: S0167-5273(13) 01071-1.
  • 6Lee HK,Ho CS,Hu M,Tomlinson B,et al.Development and valid- ation of a sensitive method for simultaneous determination ofrosuvastatinand N-desmethyl rosuvastatin in human plasma using liquid chromatography/negative electrospray ionization/tandem mass spectrometry[J]. Biomed Chrmatogr,2013,May 30.doi:10. 1002/bmc.2944.
  • 7Kim W, Hong MJ,Woo JS,et al.Rosuvastatin does not affect fas- ting glucose,insulin resistance,or adiponectin in patients with mild to moderate hypertension[J]. Chonnam Med J,2013,49(1):31-37.

二级参考文献7

  • 1Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 subjects with coronary heart disease: The Scandinavian Simvastatin Survival Study(4S). Lancet,1994,344:1383-1389.
  • 2Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA,1998,279:1615-1622.
  • 3He J, Gu D, Reynolds K, et al. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. Circulation,2004,110:405-411.
  • 4Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ) .Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.JAMA,2001,285:2486-2497.
  • 5Heart Protection Study Collaborative Group. MRC.BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high risk individuals: a randomised placebo controlled trial. Lancet, 2002,360:7-22.
  • 6Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel Ⅲ guidelines. Circulation, 2004 ,110: 227-239.
  • 7方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067

共引文献22

同被引文献22

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部